Table 1.
Patient Characteristic | N (%) |
---|---|
| |
Age (range) | 46 (22 – 76) |
| |
Primary Tumor Size (cm) | 6.5 (1 – 36.5) |
| |
Gender | |
| |
Female | 17 (34) |
Male | 33 (66) |
| |
Histology | |
| |
Gastrointestinal stromal tumor | 14 (28) |
Leiomyosarcoma | 4 (8) |
Liposarcoma* | 5 (10) |
Synovial | 3 (6) |
Chondrosarcoma | 3 (6) |
Other | 21 (42) |
| |
Original Location | |
| |
Trunk | 6 (12) |
Abdomen/Pelvis/Retroperitoneum | 30 (60) |
Head & Neck | 6 (12) |
Extremities | 8 (16) |
| |
Grade | |
| |
Low | 5 (10) |
Intermediate/High | 39 (78) |
| |
Depth | |
| |
Superficial | 3 (6) |
Deep | 45 (90) |
| |
Margins | |
| |
Negative | 34 (68) |
Positive | 13 (26) |
| |
Adjuvant Treatment | |
| |
None | 24 (48) |
Yes | 22 (44) |
No Surgery | 3 (6) |
| |
Disease status at MSKCC presentation | |
| |
No metastases | 32 (64) |
Metastases | 18 (36) |
| |
Tumor infiltrating lymphocytes | |
| |
CD3+ (%) | 3.3 (0–33.2) |
CD4+ (%) | 0.2 (0–13.6) |
CD8+ (%) | 1.2 (0–14) |
FOXP3+ (%) | 0.1 (0–3.6) |
Abbreviations: MSKCC Memorial Sloan Kettering Cancer Center, CD 3 cluster differentiation 3, CD 4 cluster differentiation 4, CD 8 cluster differentiation 8, Nuclear transcription factor forkhead box P3 (FOXP3)
subtypes of liposarcoma included myxoid liposarcoma-2, dedifferentiated liposarcoma-2, well differentiated liposarcoma -1